There goes the neighborhood: Changes in chromosome structure activate cancer-causing genes

March 3, 2016
Human chromosomes during metaphase. Credit: Steffen Dietzel/Wikipedia

In a finding with enormous implications for cancer diagnostics and therapeutics, Whitehead Institute scientists have discovered that breaches in looping chromosomal structures known as "insulated neighborhoods" can activate oncogenes capable of fueling aggressive tumor growth.

"This new understanding of the role of chromosome structure in cancer gene misregulation reveals the powerful influence of the genome's structure in human health and disease," says Whitehead Member Richard Young, whose lab's research is reported online this week in the journal Science.

Young's most recent findings build on previous work in which the lab charted human genome structure and described its influence on gene control in healthy cells. By mapping the genome's three-dimensional (3D) conformation, researchers found that key genes controlling cell identity are found in insulated neighborhoods, whose loops are maintained through anchor sites bound by the protein CTCF. All essential gene regulation, including control of proper activation and repression, takes place within these enclosed neighborhoods.

The scientists had also found that these CTCF loop anchor sites are maintained across various cell types in the human body and highly conserved in primate genomes, emphasizing their importance in normal development. Such widespread structural conservation led the researchers to hypothesize that disruptions in genome conformation might be associated with disease, including cancer.

Sure enough, subsequent systematic genomic analysis of >50 cancer cell types revealed mutations affecting CTCF anchor sites, leading to the loss of insulated neighborhood boundaries. Such neighborhood breaches were found especially frequently in T-cell acute lymphoblastic leukemia, esophageal and liver carcinoma, and in some cases allowed enhancer elements to contact and activate previously silent oncogenes.

"We hadn't known if these types of mutations contributed to cancer," says Young. "Now we have multiple examples where these disruptions activate oncogenes that play major roles in tumorigenesis."

Researchers in Young's lab note that this oncogenic mechanism is not only widespread in cancer, but may be valuable for identifying the key genes that drive poorly understood cancers.

"In some cancers, such as esophageal carcinoma, the most frequent genetic mutation occurs at the CTCF sites, which is quite striking," says Denes Hnisz, a postdoctoral researcher in the Young lab and co-first author of the Science paper. "In addition, there are still many cancers whose driver mutations and oncogenes are not known and mapping altered structures may reveal the key oncogenes in these cancers."

In a final step confirming the relationship between structural disruption and oncogenesis, Hnisz and co-first author Abe Weintraub, a graduate student in Young's lab, used genome editing techniques to introduce CTCF anchor site deletions in non-malignant cells. These mutations were sufficient to activate that are silent in normal cells.

The new findings suggest that future mapping of genome structure in individual patient cancers may improve diagnosis and help guide treatment protocols. "Now that we understand how perturbations in the genome's structure can contribute to oncogenesis, we're developing strategies to efficiently diagnose and potentially fix these faulty neighborhoods," says Weintraub.

Explore further: 3-D map of human genome reveals relationship between mutations and disease development

More information: "Activation of proto-oncogenes by disruption of chromosome neighborhoods," Science, (2016). DOI: 10.1126/science.aad9024

Related Stories

3-D map of human genome reveals relationship between mutations and disease development

December 10, 2015
Whitehead Institute researchers have created a map of the DNA loops that comprise the three dimensional (3D) structure of the human genome and regulate gene expression in human embryonic stem (ES) cells and adult cells. The ...

Novel mutational process targeting gene regulatory elements discovered

June 8, 2015
Researchers at University of Helsinki, Finland, and Karolinska Institutet, Sweden, discovered previously uncharacterized mutational patterns in the human regulatory genome, especially in gastrointestinal tract cancers.

Genetic master controls expose cancers' Achilles' heel

April 11, 2013
In a surprising finding that helps explain fundamental behaviors of normal and diseased cells, Whitehead Institute scientists have discovered a set of powerful gene regulators dubbed "super-enhancers" that control cell state ...

30-year puzzle in breast cancer solved

May 2, 2014
In a new study published today in Cell Reports, scientists at the Fred Hutchinson Cancer Research Center demonstrate that mice lacking one copy of a gene called CTCF have abnormal DNA methylation and are markedly predisposed ...

Recommended for you

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.